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Abstract
Background: Hand, foot, and mouth disease (HFMD) caused by enterovirus 71 (EV71) is very common in China. It
is difficult to distinguish between EV71 and coxsackievirus A16 (CVA16) infections in clinical HFMD patients. Routine
laboratory diagnosis of EV71 infection is time-consuming and requires expensive instruments. In this study, we
have developed a one-step, single tube, reverse transcription-loop-mediated isothermal amplification (RT-LAMP)
assay for rapid and sensitive detection of EV71.
Methods: Six primers that can recognize 6 distinct regions on the VP2 gene of EV71 were designed for RT-LAMP
assay. The amplification was completed by incubating all reagents in a single tube with reverse transcriptase and
Bst DNA polymerase under the isothermal condition (60°C) for 60 min, and could be evaluated by using GoldView
staining under a handheld ultraviolet torch lamp or electrophoresis analysis.
Results: A total of 123 specimens collected from suspicious patients with HFMD were simultaneously detected by
RT-LAMP and PCR fluorescence probing assay. The RT-LAMP amplified products containing EV71 were digested by
HinfI and TaqI restriction endonucleases; in contrast, non-specific products with CVA16, coxsackievirus A4 and
coxsackievirus B3 could not be detected in RT-LAMP assay. Meanwhile, RT-LAMP assay could amplify EV71 virus
with a detection limit of 1 PFU/ml within 60 min. Compared with PCR fluorescence probing assay, RT-LAMP assay
exhibited 98.4% identity during the detection of EV71 viral RNA without the missing of positive samples.
Conclusion: Our results indicated that RT-LAMP is a rapid, sensitive, specific and accurate method for the
detection of EV71 in clinical specimens. Therefore, this developed method has potential application for rapid and
comprehensive surveillance for EV71 infection, especially in developing country.
Background
HFMD, a common illness in children, can be caused by
many human enteroviruses such as coxsackie viruses
A4, A5, A6, A10, A16, B1, B3, and EV71 [1-4]. Among
these viruses, human EV71 and CVA16 are major causa-
tive agents of HFMD. EV71 and CVA16 infections in
HFMD are indistinguishable. However, EV71 infection is
frequently associated with serious neurological compli-
cations and fatalities [5]. EV71 was initially isolated
from the stool of a 9-month-old infant with fatal ence-
phalitis in California in 1969 [6]. Subsequently, the pre-
valence of EV71 infection has been reported in many
countries and regions, such as Taiwan, Hongkong,
Malaysia and Singapore, as well as Guangdong, Hunan,
Jiangsu and Fuyang in China [7-13]. EV71 and CVA16
infections mainly occurred in children under 5 years
old. However, patients infected with EV71 are liable to
cause aseptic meningitis, encephalomyelitis, and pul-
monary edema [14,15].
Traditional EV71 infection is primarily dependent on
serodiagnosis, and virus culture and identification. How-
ever, these methods are time-consuming and easy to
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produce cross-immune response with CVA16. Recently,
reverse transcription-PCR (RT-PCR) and real-time PCR
assays have been used for EV71 detection [16-18]. These
nucleic acid amplification methods with intrinsic disad-
vantages of requiring sophisticated instrumentations and
expensive reagents may not be the best choice for basic
clinical settings in developing countries or in field situa-
tions. Therefore, it is necessary to develop a rapid, reli-
able, and simple molecular test to take the place of
existing techniques. In 2000, a newly developed LAMP
method with the characteristics of simplicity, rapidity,
specificity, and cost-effectiveness has the potential to
replace PCR [19]. LAMP is based on the principle of
strand displacement reaction so that the stem-loop
structure can amplify the target with high specificity,
selectivity and rapidity under isothermal conditions.
LAMP can also produce a large amount of target DNA
and by-product magnesium pyrophosphate for the for-
mation of turbidity. Therefore, LAMP assays have been
widely used to detect a variety of infectious diseases,
such as bacterial, fungus and viral infections [20-22].
Nowadays, the application of LAMP method in EV71
detection was less reported [23]. In the present study,
we have developed a one-step, single-tube, and real-time
RT-LAMP assay to detect EV71. The amplified products
can be stained by double-stranded DNA binding fluores-
cent dye (GoldView stain), and observed through naked
eyes under the UV lamp. Compared with PCR fluores-
cence probing assay, RT-LAMP had high sensitivity and
specificity during EV71 detection, which is suitable for
the application in primary health care agencies.
Methods
Specimen collection
A total of 123 suspicious patients with HFMD under 5
years old were enrolled in 2009 in Changzhou, China.
This study was approved by the local ethics committee
and all patients were provided a written informed
consent. Totally 93 pharyngeal swabs, 20 vesicular fluid
swabs and 10 fecal samples were collected from these
patients within 4 days after the onset of infection, and
stored in 3-5 ml of preservation solution (Hanks solu-
tion containing 10 μg/ml gentamicin and 0.25 μg/ml
amphotericin B) at -70°C for analysis.
Virus isolation and identification
Specimens were inoculated into rhabdomyosarcoma (RD)
cells for the isolation of EV71. Enterovirus strains were
identified by using immunofluorescence test with EV71
monoclonal antibody (Chemicon International Inc.).
Primer design for RT-LAMP
Six primers were designed according to the VP2 gene
sequences of EV71 virus published in GenBank (acces-
sion No. AY465356), and was aligned with available VP2
gene sequences of other strains, including the circulating
strains in China responsible for recent epidemics, to
identify the conserved regions using DNASIS software.
The potential target region of 194 bp corresponding to
the genome positions from 1296 to 1489 was selected
from the aligned sequences, including two inner, two
outer primers and two loop primers (Figure 1). Two
inner primers were called the forward inner primer
(FIP) and the backward inner primer (BIP), which con-
tained two distinct sequences corresponding to the
sense and antisense sequences of the target DNA, for
priming in the first stage and self-priming in later stage,
respectively. FIP contained the sequence (F1c) comple-
mentary to F1 and F2. BIP contained B1 and the
sequence (B2c) complementary to B2. Two outer pri-
mers were composed of F3 and the sequence (B3c)
complementary to B3 (Table 1).
Extraction of viral RNA
Prior to RNA extraction, fecal samples were treated with
chloroform according to the protocol described
Figure 1 Sequences of RT-LAMP primers for EV71.
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elsewhere [24]. The genomic viral RNA was extracted
from 100 μl of swab specimens or pretreated feces by
using the QIAamp viral RNA extraction kit (Qiagen,
Germany) according to the manufacturer’s instructions.
The RNA was eluted from the QIAspin columns in a
final volume of 100 μl of elution buffer and kept at -70°
C until further analysis.
Reaction system of RT-LAMP
The RT-LAMP reaction was performed in a 25 μl of
reaction mixture containing 0.8 μM (each) FIP and
BIP inner primers, 0.2 μM forward outer primer (F3)
and backward outer primer (B3), 0.4 μM LF and LB
(each), 0.4 mM deoxynucleoside triphosphates
(dNTPs), 1 M betaine (Sigma, USA), 20 mM Tris-HCl
(pH 8.8), 10 mM KCl, 10 mM (NH4)2SO4, 2.8 mM
MgSO4, 0.1% Triton X-100, 0.5 μl of 8 U Bst DNA
polymerase (New England Biolabs, USA), 40 U of
reverse transcriptase (Invitrogen), and 5 μl of target
RNA. Six temperatures (60, 61, 62, 63, 64 and 65°C)
were screened during RT-LAMP assay, and finally the
optimal temperature was monitored by agarose gel
electrophoresis. Amplification was completed in PCR
microtubes in an electric thermostatic water bath
(Suopu, Shanghai, China) at the isothermal condition
of 60°C for 60 min. GoldView dye (Sbsgene, China)
was used to evaluate the reaction system with the
reference of a negative control and a positive control.
The samples with fluorescence change from orange to
red or from orange to green were considered as the
negative and positive reactions under ultraviolet (UV)
light (254 nm) with a handheld lamp.
PCR fluorescence probing assay and nucleotide
sequencing
The PCR fluorescence probing assay reagent (DaAn
Gene, China) was commercially available. The cDNA
was generated in a 20 μl of reaction volume for 25 min
at 40°C using random primers and SuperScript II
reverse transcriptase (Invitrogen) according to the
instructions. The cycling conditions were composed of 5
min at 94°C, followed by 40 cycles with 93°C for 15 s,
55°C for 45 s, and 72°C for 1 min, and a final extension
cycle of 72°C for 10 min. The PCR products were exam-
ined by Lighter cycler (Roche, Germany). Forward pri-
mer EV71-F: 5’-AAA GGT GGA GCT GTT CAC CTA
CAT GCG CTT TGA C-3’, reverse primer EV71-R: 5’-
AAT CTG GCT TGG GGG CCC CAG GTG GTA
CAA-3’, and oligonucleotide probe EV71-P: 5’-CCC
ACC GGG GAA GTT GTC CCA CAA TTG CTC C-3’.
The specific oligonucleotide probes were added, and the
results were considered as the positive for Ct value not
higher than 35.1. All amplicons were sequenced with an
ABI 3730 automated DNA sequencer (Applied
Biosystems).
Specificity of RT-LAMP assay
A restriction analysis by using HinfI or TaqI endonu-
clease was used to validate the specificity of EV71
amplification reaction. Enzymatic reaction system is
composed as follows: 2 μl of RT-LAMP product, 15 μl
of ddH2O, 1 μl of 10 × buffer R, 1 μl of HinfI or TaqI
for 10 U/μl (each). The digestion reactions of HinfI or
TaqI were incubated at 37°C and 65°C for 2 h, respec-
tively. Finally, 1.5 μl of digested RT-LAMP products
were analyzed by agarose gel electrophoresis. Four virus
strains of EV71, CVA16, coxsackievirus A4 (CVA4), and
coxsackievirus B3 (CVB3) were provided by China Cen-
ter for Type Culture Collection and Changzhou Center
for Disease Control, respectively.
Sensitivity of RT-LAMP and PCR fluorescence probing
assay
The EV71 or CVA16 was propagated in RD cells, and
the titer was determined by plaque assay in vero cells
[25,26]. Totally 0.5 ml virus culture at various concen-
trations ranging from 105 to 0.1 PFU/ml in a serial 10-
fold dilution pattern was detected by RT-LAMP and
PCR fluorescence probing assay. The products of RT-
LAMP were detected by agarose gel electrophoresis.
EV71 detection in clinical specimens by RT-LAMP and PCR
fluorescence probing assay
Totally 93 pharyngeal swabs, 20 vesicular fluid swabs
and 10 fecal samples with suspicious EV71 infection
were extracted as described above and analyzed by RT-
Table 1 The RT-LAMP primers
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LAMP and PCR fluorescence probing assays with the
reference of negative and positive control reactions con-
taining CVA16 and EV71.
Statistical analysis
Statistically significant analysis of the clinical study was
evaluated by using chi-square test. A significant differ-
ence was considered at the P value of less than 0.05.
Results
The optimum reaction system of RT-LAMP assay
The optimal temperature for RT-LAMP reaction was
determined to be 60°C, which could provide the optimal
activity of Bst DNA polymerase (Figure 2A). Similarly,
the optimal reaction time and concentrations of magne-
sium and betaine were identified as 60 min, 2.8 mM
and 1 M, respectively (Figure 2B, C and 2D). Under the
GoldView staining, positive samples revealed the fluor-
escence change from orange to green (Figure 3).
Restriction enzyme analysis of RT-LAMP products
The specificity of RT-LAMP was confirmed by the
digestion using HinfI and TaqI restriction enzymes. The
amplified products with EV71 resulted in a series of
bands in agarose gel electropherosis. In contrast, non-
specific products with CVA16, CVA4 and CVB3 in RT-
LAMP assay could not be detected (Figure 4).
Sensitivity of EV71 virus by RT-LAMP amplification
The sensitivity of RT-LAMP and PCR fluorescence
probing assay for the detection of EV71 RNA was evalu-
ated by testing serial 10-fold dilutions of virus through
previously described as plaque assay. The RT-LAMP
assay was able to amplify a small amount of virus in 60
min with a detection limit of 1 PFU/ml of virus (Figure
5A and 5B). RT-LAMP revealed 100-fold higher sensi-
tivity than PCR fluorescence probing assay, which had a
detection limit of 100 PFU (copy)/ml of virus (Figure 6).
Detection of 123 clinical specimens
In order to assess the diagnostic accuracy for suspi-
cious patients with EV71 infection, 123 specimens
were subjected to RT-LAMP assay with the parallel
analysis by PCR fluorescence probing assay. The ampli-
cons were sequenced. As shown in Table 2, an overall
similarity between two test systems was 98.4% (P
>0.05). No samples with positive reaction detected by
PCR fluorescence probing assay was missed during
Figure 2 The optimal condition of RT-LAMP for the detection of EV71. (2A) The optimal temperature of RT-LAMP assay is monitored by
agarose gel analysis. M: Marker, 100-bp DNA ladder (Sigma, USA); Lanes 1-6 are reaction temperatures at 60, 61, 62, 63, 64 and 65°C, respectively.
(2B) The reaction time of RT-LAMP. Lanes 1-5 are reaction time of 30, 40, 50, 60 and 70 min, respectively. (2C) The concentration of magnesium.
Lanes 1-5 are magnesium at the concentrations of 0, 1, 2, 2.8 and 3.6 mM, respectively. (2D) The concentration of betaine. Lanes 1-4 are the
betaine concentrations of 0, 0.5, 1.0 and 1.5 M, respectively.
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RT-LAMP assay, thereby indicating the superior sensi-
tivity of RT-LAMP. Two positive samples detected by
RT-LAMP assay but PCR fluorescence probing assay
negative were then inoculated into RD cells and the
positive culture was identified by indirect immuno-
fluorescence test; however, only one sample was
verified as positive EV71 infection. The positive rates
of 93 pharyngeal swabs detected by RT-LAMP and
PCR fluorescence probing assay were 44.1 and 41.9%,
respectively, and the positive rates of 20 vesicular fluid
swabs and 10 fecal samples detected by both methods
were 60.0% and 50.0% (Table 2).
Figure 3 GoldView staining of the samples. Samples with the
fluorescence change from orange to green under UV lamp at a 254
nm are considered as positive (Lanes 2 and 3), while a sample with
fluorescence change from orange to red is considered as negative
(Lane 1).
Figure 4 Agarose gel electrophoresis and restriction analysis of
RT-LAMP products. M: Marker, 100-bp DNA ladder (Sigma, USA);
Lanes 1 and 3 are RT-LAMP products digested with HinfI and TaqI,
respectively; Lanes 2 and 4 are RT-LAMP amplified products; Lanes
5-7 are CVA16, CVA4 and CVB3 negative controls, respectively.
Figure 5 The detection sensitivity of LAMP assay for EV71. (5A) The electrophoresis diagram of RT-LAMP with virus serial dilution. M: Marker,
100-bp DNA ladder (Sigma, USA). N: negative control without target DNA. Lanes 1-8 are target DNA at 105, 104, 103, 102, 10, 1, 0.1, and 0 PFU/ml,
respectively. (5B) Goldview staining of serial dilution reaction. N: Negative. Lanes 1-7; target DNA at 105, 104, 103, 102, 10, 1 and 0.1 PFU/ml,
respectively.
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Discussion
Human enterovirus belongs to the RNA virus family
Picornaviridae including polioviruses, type A coxsackie-
viruses, type B coxsackieviruses, echoviruses, and enter-
ovirus types 68 to 71 (EV68-71) [15,27]. Due to the
prevalence of EV71 infection, time-consuming viral cul-
ture and serological tests for EV71, it is important to
develop fast, efficient and sensitive diagnostic reagents
[28,29]. Although PCR technique has been widely used
in the detection of infectious diseases and the real-time
PCR assay has multiple advantages such as faster quanti-
tative measurement, lower contamination rate, higher
sensitivity, higher specificity and easier standardization,
these nucleic acid amplification methods require high-
precision instruments and skilled technicians [30,31].
LAMP is a nucleic acid amplification method that
relies on autocycling strand displacement DNA synthesis
completed by Bst DNA polymerase. Because of high
sensitivity and specificity coupled with the requirements
for only a water bath and endpoint detection using a
color-change reaction visible with the naked eye [32-34],
LAMP assay has been applied for the analysis of various
infections from Mycobacterium tuberculosis, Norovirus,
Human papillomavirus, Cytomegalovirus, and Human
immunodeficiency virus [20,35-38].
In this study, a one-step and simple assay for EV71
virus without requirement of thermal cycling can be
completed within 60 min in a single tube containing the
mixture of buffer, primers, reverse transcriptase and Bst
DNA polymerase. In order to ensure its accuracy and
reliable amplification, it is very important to optimize
the reaction temperature. At the optimal reaction tem-
perature of 60°C, clear bands of amplified products were
observed in gel electrophoresis.
Similarly, the optimal reaction time, magnesium and
betaine concentrations were achieved. Except for ampli-
fied products detected by agarose gel electrophoresis as
described above, two alternative detection methods
could also be used for the evaluation. 1) Turbidity: the
accumulation of magnesium pyrophosphate, a by-pro-
duct of amplified DNA, results in the increase of the
turbidity in samples. The turbidity in samples was evalu-
ated by visual inspection. However, when the virus con-
tent of samples is low, it is difficult to observe the
Figure 6 The detection sensitivity of PCR fluorescence probing assay. P: EV71 positive control; RNA samples (104 PFU/ml) with 10-1-10-3
dilutions, respectively.
Table 2 Comparison of 123 specimens from suspicious HFMD patients were analyzed by RT-LAMP and PCR
fluorescence probing assay
Specimen type Number of samples RT-LAMP PCR fluorescence probing
*Positive (%) #Negative (%) Positive (%) Negative (%)
Pharyngeal swabs 93 41 (44.1) 52 (55.9) 39 (41.9) 54 (58.1)
Vesicular fluids 20 12 (60.0) 8 (40.0) 12 (60.0) 8 (40.0)
Fecal samples 10 5 (50.0) 5 (50.0) 5 (50.0) 5 (50.0)
Total 123 58 (47.2) 65 (52.8) 56 (45.5) 67 (54.4)
*Positive: EV71 positive samples; #Negative: EV71 negative samples.
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turbidity by visual inspection. 2) Fluorescence change:
GoldView staining was used for evaluating the amplifi-
cation. Samples with the fluorescence conversion from
orange to green or from orange to red under an UV
handheld lamp at a 254 nm were considered as the posi-
tive and negative, respectively. Different from traditional
ethidium bromide (EB) for detecting double-stranded
DNA, single-stranded DNA, and RNA, Goldview stain-
ing can emit green fluorescence when bound to dsDNA
and red fluorescence when bound to ssDNA or RNA.
However, compared to EB with strong mutagen, Gold-
view has relatively fewer mutations and higher safety.
Particularly, similar clinical symptoms in infections
caused by EV71 and CVA16 with high similarity in
nucleotide sequences were observed. Therefore, frequent
mis-diagnosis between EV71 and CVA16 infections was
happened due to the difficulty in distinguishing both
viruses [39]. However, exact nucleotide sequences of
RT-LAMP products can be predicted from target DNA
and primers. Thus, it is possible to predict the digestion
outcome of the samples with restriction enzymes at the
specific recognition sites. In the present study, the speci-
fic products could be digested by HinfI and TaqI restric-
tion enzymes to result in a series of bands in agarose gel
electrophoresis, in contrast, non-specific products could
not be detected due to without digestion. Therefore,
RT-LAMP assay can provide high specificity for the
detection of EV71.
The sensitivity of RT-LAMP assay for EV71 detection
was determined by testing serial 10-fold dilutions of
virus with a detection limit of 1 PFU/ml. In order to
evaluate the reliability of RT-LAMP, 123 suspicious
samples were simultaneously detected by PCR fluores-
cence probing assay and RT-LAMP. Both test systems
had 98.4% similarity without significant difference. With
a detection limit of 1 PFU/ml, RT-LAMP assay exhib-
ited much higher sensitivity than PCR fluorescence
probing assay, as well as virus culture. Between two
positive samples identified by RT-LAMP but PCR fluor-
escence probing assay negative, only one sample was
verified as EV71 infection by virus culture and indirect
immunofluorescence test, which further confirmed the
higher sensitivity of RT-LAMP assay.
Besides pharyngeal, vesicular fluid and stool, RT-
LAMP can be used to detect other samples such as cer-
ebrospinal fluid, etc. However, the application of RT-
LAMP in these samples needs to be further explored to
provide more evidences in the early diagnosis of EV71
infection.
Conclusions
RT-LAMP assay is characteristics of high sensitivity,
rapid detection, high specificity and low cost, which has
considerable potentials for the detection of EV71
infection in the primary health care institutions, field
environments or developing countries.
Acknowledgements
We thank Guanghua Luo and Yuehua Feng for their help in the LAMP assay
and electrophoresis analysis.
Author details
1Department of Clinical Laboratory, The Third Affiliated Hospital of Suzhou
University, No. 185 Juqian street, Changzhou, Jiangsu 213003, P. R. China.
2Wuxi Clone Gen-Tech Institute, No. 26 Fenghua Road, Wuxi, Jiangsu 214026,
P. R. China.
Authors’ contributions
WS conceived the study, carried out the molecular genetic studies, analyzed
the data and drafted the manuscript; KL and YJ participated in the design
and carrying out specimen collection; QJ performed PCR-Fluorescence
probing assay, agar gel electrophoresis and analyzed the data; MS and ZM
helped coordinate the investigation and participated in LAMP assay. All
authors contributed to the study and have read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 5 March 2011 Accepted: 18 July 2011 Published: 18 July 2011
References
1. Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, Quak SH, Chow VT: The largest
outbreak of hand; foot and mouth disease in Singapore in 2008:the role
of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis 2010, 14:
e1076-1081.
2. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH:
Virology, epidemiology, pathogenesis, and control of enterovirus 71.
Lancet Infect Dis 2010, 10:778-790.
3. Davia JL, Bel PH, Ninet VZ, Bracho MA, Gonzalez-Candelas F, Salazar A,
Gobernado M, Bosch IF: Onychomadesis outbreak in Valencia, Spain
associated with hand, foot, and mouth disease caused by enteroviruses.
Pediatr Dermatol 2011, 28:1-5.
4. Zhou F, Kong F, Wang B, McPhie K, Gilbert GL, Dwyer DE: Molecular
characterization of enterovirus 71 and coxsackievirus A16 using the
5’untranslated region and VP1 region. Journal of medical microbiology
2011, 60:349-358.
5. Schuffenecker I, Mirand A, Antona D, Henquell C, Chomel JJ,
Archimbaud C, Billaud G, Peigue-Lafeuille H, Lina B, Bailly JL:
Epidemiology of human enterovirus 71 infections in France, 2000-
2009. J Clin Virol 2010, 50:50-56.
6. Schmidt NJ, Lennette EH, Ho HH: An apparently new enterovirus isolated
from patients with disease of the central nervous system. J Infect Dis
1974, 129:304-309.
7. Huang SW, Hsu YW, Smith DJ, Kiang D, Tsai HP, Lin KH, Wang SM, Liu CC,
Su IJ, Wang JR: Reemergence of enterovirus 71 in 2008 in taiwan:
dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin
Microbiol 2009, 47:3653-3662.
8. Ma E, Lam T, Chan KC, Wong C, Chuang SK: Changing epidemiology of
hand, foot, and mouth disease in Hong Kong, 2001-2009. Jpn J Infect Dis
2010, 63:422-426.
9. Tee KK, Takebe Y, Kamarulzaman A: Emerging and re-emerging viruses in
Malaysia, 1997-2007. Int J Infect Dis 2009, 13:307-318.
10. Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE: Epidemic hand, foot
and mouth disease caused by human enterovirus 71, Singapore. Emerg
Infect Dis 2003, 9:78-85.
11. Zhu Z, Zhu S, Guo X, Wang J, Wang D, Yan D, Tan X, Tang L, Zhu H,
Yang Z, Jiang X, Ji Y, Zhang Y, Xu W: Retrospective seroepidemiology
indicated that human enterovirus 71 and coxsackievirus A16 circulated
wildly in central and southern China before large-scale outbreaks from
2008. Virol J 2010, 7:300.
12. Mao LX, Wu B, Bao WX, Han FA, Xu L, Ge QJ, Yang J, Yuan ZH, Miao CH,
Huang XX, Zhang C, Xu H: Epidemiology of hand, foot, and mouth
Shi et al. BMC Infectious Diseases 2011, 11:197
http://www.biomedcentral.com/1471-2334/11/197
Page 7 of 8
disease and genotype characterization of Enterovirus 71 in Jiangsu,
China. J Clin Virol 2010, 49:100-104.
13. Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A,
Yan D, Li Q, Dong X, Zhang J, Zhao Y, Wan J, Feng Z, Sun J, Wang S, Li D,
Xu W: An emerging recombinant human enterovirus 71 responsible for
the 2008 outbreak of hand foot and mouth disease in Fuyang city of
China. Virol J 2010, 7:94.
14. Komatsu H, Shimizu Y, Takeuchi Y, Ishiko H, Takada H: Outbreak of severe
neurologic involvement associated with Enterovirus 71 infection. Pediatr
Neurol 1999, 20:17-23.
15. Shah VA, Chong CY, Chan KP, Ng W, Ling AE: Clinical characteristics of an
outbreak of hand, foot and mouth disease in Singapore. Ann Acad Med
Singapore 2003, 32:381-387.
16. Chen TC, Chen GW, Hsiung CA, Yang JY, Shih SR, Lai YK, Juang JL:
Combining multiplex reverse transcription-PCR and a diagnostic
microarray to detect and differentiate enterovirus 71 and coxsackievirus
A16. J Clin Microbiol 2006, 44:2212-2219.
17. Tan EL, Yong LL, Quak SH, Yeo WC, Chow VT, Poh CL: Rapid detection of
enterovirus 71 by real-time TaqMan RT-PCR. J Clin Virol 2008, 42:203-206.
18. Xiao XL, He YQ, Yu YG, Yang H, Chen G, Li HF, Zhang JW, Liu DM, Li XF,
Yang XQ, Wu H: Simultaneous detection of human enterovirus 71 and
coxsackievirus A16 in clinical specimens by multiplex real-time PCR with
an internal amplification control. Arch Virol 2009, 154:121-125.
19. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N,
Hase T: Loop-mediated isothermal amplification of DNA. Nucleic Acids Res
2000, 28:E63.
20. Lee MF, Chen YH, Peng CF: Evaluation of reverse transcription loop-
mediated isothermal amplification in conjunction with ELISA-
hybridization assay for molecular detection of Mycobacterium
tuberculosis. J Microbiol Methods 2009, 76:174-180.
21. Sun J, Najafzadeh MJ, Vicente V, Xi L, de Hoog GS: Rapid detection of
pathogenic fungi using loop-mediated isothermal amplification,
exemplified by Fonsecaea agents of chromoblastomycosis. J Microbiol
Methods 2010, 80:19-24.
22. Parida MM, Santhosh SR, Dash PK, Tripathi NK, Saxena P, Ambuj S, Sahni AK,
Lakshmana Rao PV, Morita K: Development and evaluation of reverse
transcription-loop-mediated isothermal amplification assay for rapid and
real-time detection of Japanese encephalitis virus. J Clin Microbiol 2006,
44:4172-4178.
23. Jiang T, Liu J, Deng YQ, Xu LJ, Li XF, Han JF, Cao RY, Qin ED, Qin CF:
Development and evaluation of a reverse transcription-loop-mediated
isothermal amplification assay for rapid detection of enterovirus 71. J
Clin Microbiol 2011, 49:870-874.
24. Nix WA, Oberste MS, Pallansch MA: Sensitive, seminested PCR
amplification of VP1 sequences for direct identification of all enterovirus
serotypes from original clinical specimens. J Clin Microbiol 2006,
44:2698-2704.
25. Kasahara T, Shioiri-Nakano K, Sugiura A: Virus plaque assay: effective
detection of virus plaque forming cells at the early stage of lymphocyte
activation by mitogen and alloantigen. Immunology 1979, 36:381-390.
26. Langlet J, Gaboriaud F, Gantzer C: Effects of pH on plaque forming unit
counts and aggregation of MS2 bacteriophage. J Appl Microbiol 2007,
103:1632-1638.
27. Frydenberg A, Starr M: Hand, foot and mouth disease. Aust Fam Physician
2003, 32:594-595.
28. Van Doornum GJ, De Jong JC: Rapid shell vial culture technique for
detection of enteroviruses and adenoviruses in fecal specimens:
comparison with conventional virus isolation method. J Clin Microbiol
1998, 36:2865-2868.
29. Mizuta K, Aoki Y, Suto A, Ootani K, Katsushima N, Itagaki T, Ohmi A,
Okamoto M, Nishimura H, Matsuzaki Y, Hongo S, Sugawara K, Shimizu H,
Ahiko T: Cross-antigenicity among EV71 strains from different
genogroups isolated in Yamagata, Japan, between 1990 and 2007.
Vaccine 2009, 27:3153-3158.
30. Fout GS, Martinson BC, Moyer MW, Dahling DR: A multiplex reverse
transcription-PCR method for detection of human enteric viruses in
groundwater. Appl Environ Microbiol 2003, 69:3158-3164.
31. Jimenez-Clavero MA, Escribano-Romero E, Mansilla C, Gomez N, Cordoba L,
Roblas N, Ponz F, Ley V, Saiz JC: Survey of bovine enterovirus in biological
and environmental samples by a highly sensitive real-time reverse
transcription-PCR. Appl Environ Microbiol 2005, 71:3536-3543.
32. Imai M, Ninomiya A, Minekawa H, Notomi T, Ishizaki T, Van Tu P, Tien NT,
Tashiro M, Odagiri T: Rapid diagnosis of H5N1 avian influenza virus
infection by newly developed influenza H5 hemagglutinin gene-specific
loop-mediated isothermal amplification method. J Virol Methods 2007,
141:173-180.
33. Fukuta S, Iida T, Mizukami Y, Ishida A, Ueda J, Kanbe M, Ishimoto Y:
Detection of Japanese yam mosaic virus by RT-LAMP. Arch Virol 2003,
148:1713-1720.
34. Morishita S, Tani H, Kurata S, Nakamura K, Tsuneda S, Sekiguchi Y, Noda N:
Real-time reverse transcription loop-mediated isothermal amplification
for rapid and simple quantification of WT1 mRNA. Clin Biochem 2009,
42:515-520.
35. Fukuda S, Takao S, Kuwayama M, Shimazu Y, Miyazaki K: Rapid detection of
norovirus from fecal specimens by real-time reverse transcription-loop-
mediated isothermal amplification assay. J Clin Microbiol 2006,
44:1376-1381.
36. Hagiwara M, Sasaki H, Matsuo K, Honda M, Kawase M, Nakagawa H: Loop-
mediated isothermal amplification method for detection of human
papillomavirus type 6, 11, 16, and 18. J Med Virol 2007, 79:605-615.
37. Reddy AK, Balne PK, Reddy RK, Mathai A, Kaur I: Development and
evaluation of loop-mediated isothermal amplification assay for rapid
and inexpensive detection of cytomegalovirus DNA in vitreous
specimens from suspected cases of viral retinitis. J Clin Microbiol 2010,
48:2050-2052.
38. Hosaka N, Ndembi N, Ishizaki A, Kageyama S, Numazaki K, Ichimura H:
Rapid detection of human immunodeficiency virus type 1 group M by a
reverse transcription-loop-mediated isothermal amplification assay. J
Virol Methods 2009, 157:195-199.
39. Miao LY, Pierce C, Gray-Johnson J, DeLotell J, Shaw C, Chapman N, Yeh E,
Schnurr D, Huang YT: Monoclonal antibodies to VP1 recognize a broad
range of enteroviruses. J Clin Microbiol 2009, 47:3108-3113.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/11/197/prepub
doi:10.1186/1471-2334-11-197
Cite this article as: Shi et al.: Development and evaluation of reverse
transcription-loop-mediated isothermal amplification assay for rapid
detection of enterovirus 71. BMC Infectious Diseases 2011 11:197.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Shi et al. BMC Infectious Diseases 2011, 11:197
http://www.biomedcentral.com/1471-2334/11/197
Page 8 of 8
